{
  "ticker": "XLO",
  "year": 2024,
  "quarter": 2,
  "last_updated": "2025-04-19T08:46:13.654982",
  "count": 8,
  "transactions": [
    {
      "id": 25661,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 41980,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 61305,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 82899,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 106839,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 132749,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 160612,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    },
    {
      "id": 190848,
      "issuer_name": "Xilio Therapeutics, Inc.",
      "reporting_owner": "GILEAD SCIENCES, INC.",
      "reporting_owner_cik": "0000882095",
      "reporting_owner_position": null,
      "transaction_date": "2024-04-02",
      "transaction_shares": "485250",
      "transaction_price": "0.76",
      "transaction_type": "P",
      "shares_after_transaction": "7345473"
    }
  ]
}